Company: RNAC
Filing Date: 2025-04-08
Form Type: 8-K
Source: 0001453687-25-000064
Chunk: 3

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-04-08
Form: 8-K
Item: Item 8.01
Chunk 3
---
able operating expenses and capital expenditure requirements, the Company’s recurring losses from operations and negative cash flows, substantial fluctuation in the price of the Company’s common stock, risks related to geopolitical conflicts and pandemics and other important factors discussed in the “ Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q, and in other filings that the Company makes with the Securities and Exchange Commission. In addition, any forward-looking statements included in this Current Report on Form 8-K represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company specifically disclaims any intention to update any forward-looking statements included in this Current Report on Form 8-K, except as required by law.

Item 9.01 Financial Statements and Exhibits.